Procurement Summary
Country : Serbia
Summary : Medications Outside the List of Drugs
Deadline : 29 May 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 119086765
Document Ref. No. : A257/2025
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Apomorphine hydrochloride, apomorphine hydrochloride hemihydrate \ t, asciminib \ t, avelumab \ t, baclofen in intrathecial pump, which proves a certified SMPC translation to the Serbian language in which this stability data is listed) \ t, balancedCombination of 9 trace traces 20x10ml amp (copper, selenium, manganese, chromium, zinc, iron), Baloxavir Marboksil \ t, Benralizumab \ t, Dexametzam \ t, Durvalumab \ t, Ekulizumab \ t, Etelkalcetid \ t, evolokumab \ t, Faricimab \ t, fremnezumab \ t, fruquintinib \ t, fruquintinib \ t, GancicLovir \ t, givosiran \ t, human normal IG for IV. In need that contains 76% IgG, 12% IGM and 12% IGA \ t
Status of the procedure: - Client University Clinical Center of Serbia Purchaser RS110 - Belgrade Oblast, BelgradeName of procurement medications outside drug list Reference number A257 / 2025 Type of itemA good estimated value of the type of procedure open procedureDeadline for submission 29.05.2025 09:00:00 Status of the procedure Published by submission deadline:29.05.2025 09:00:00
Documents
Tender Notice